CDC73 and hyperparathyroidism 2 with jaw tumors: HPT-JT is a hereditary autosomal dominant disorder with variable and incomplete penetrance with a 15–20% risk of developing PC [24]; thus, germline CDC73 mutation testing should be recommended for all patients with PC.